Global Indemnity Group, LLC - Class A Common Stock (GBLI)

Global Indemnity's Q3 2025 earnings beat profit forecasts with $1.08 EPS, though revenue missed. The stock rose on strong underwriting income and strategic growth initiatives.

GBLI stock results show that Global Indemnity Group beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million.